Anika Therapeutics, Inc.

All amounts in Millions of	except per share items
Select start date for annual reports

BALANCE SHEET (at a glance)
	2004/12	2005/12	2006/12	2007/12	2008/12

INDICATORS
year end date	2004/12	2005/12	2006/12	2007/12	2008/12
date preliminary data loaded	2005-03-24	2006-03-03	2007-03-01	2008-03-13	2009-04-15
earnings period indicator	F	F	F	F	F
quarterly indicator	4	4	4	4	4
basic earnings indicator	Y	Y	Y	Y	Y
template indicator
preliminary full context ind	N	N	N	N	N
projected fiscal year date	0000-00-00	0000-00-00	0000-00-00	0000-00-00	0000-00-00
number of months last report period	12	12	12	12	12
INCOME STATEMENT
operating revenue	26.5	29.8	26.8	30.8	35.8
total revenue	26.5	29.8	26.8	30.8	35.8
adjustments to revenue	0.0	0.0	0.0	0.0	0.0
cost of sales	9.2	10.7	10.7	11.1	11.8
cost of sales with depreciation	9.9	11.1	11.1	11.9	13.2
gross margin	16.5	0.0	0.0	0.0	0.0
gross operating profit	17.2	19.2	16.1	19.8	24.0
Research & Development (R&D) Expense	4.1	4.7	3.6	4.4	7.4
Selling, General & Administrative (SG&A) Expense	6.0	5.4	6.7	8.0	11.0
advertising	0.0	0.0	0.0	0.0	0.0
operating income	6.4	8.6	5.4	6.6	4.2
EBITDA	7.1	9.0	5.8	7.4	5.7
depreciation	0.7	0.5	0.4	0.8	1.4
depreciation (unrecognized)	0.0	0.0	0.0	0.0	0.0
amortization	0.0	0.0	0.0	0.0	0.0
amortization of intangibles	0.0	0.0	0.0	0.0	0.0
operating profit after depreciation	6.4	8.6	5.4	6.6	4.2
interest income	0.4	1.2	2.1	2.1	0.5
earnings from equity interest	0.0	0.0	0.0	0.0	0.0
other income net	0.0	0.0	0.0	0.0	0.0
income, acquired in process r&a	0.0	0.0	0.0	0.0	0.0
Income, Restructuring and M&A	0.0	0.0	0.0	0.0	0.0
other special charges	0.0	0.0	0.0	0.0	0.0
special income charges	0.0	0.0	0.0	0.0	0.0
EBIT	6.8	9.8	7.5	8.7	4.7
interest expense	0.0	0.0	0.0	0.0	0.0
pre-tax income	6.8	9.8	7.5	8.7	4.7
income taxes	-4.4	3.9	2.9	2.7	1.1
minority interest	0.0	0.0	0.0	0.0	0.0
pref. securities of subsid. trust	0.0	0.0	0.0	0.0	0.0
income before income taxes	6.8	9.8	7.5	8.7	4.7
net income (continuing operations)	11.2	5.9	4.6	6.0	3.6
net income (discontinued operations)	0.0	0.0	0.0	0.0	0.0
net income (total operations)	11.2	5.9	4.6	6.0	3.6
extraordinary income/losses	0.0	0.0	0.0	0.0	0.0
income from cum. effect of acct. change	0.0	0.0	0.0	0.0	0.0
income from tax loss carryforward	0.0	0.0	0.0	0.0	0.0
other gains/losses	0.0	0.0	0.0	0.0	0.0
total net income	11.2	5.9	4.6	6.0	3.6
normalized income	11.2	5.9	4.6	6.0	3.6
net income available for common	11.2	5.9	4.6	6.0	3.6
preferred dividends	0.0	0.0	0.0	0.0	0.0
excise taxes	0.0	0.0	0.0	0.0	0.0
*
Basic EPS (Continuing)	1.11	0.57	0.43	0.55	0.32
Basic EPS (Discontinued)	0.00	0.00	0.00	0.00	0.00
Basic EPS from Total Operations	1.11	0.57	0.43	0.55	0.32
Basic EPS (Extraordinary Items)	0.00	0.00	0.00	0.00	0.00
Basic EPS (Cum. Effect of Acct. Change)	0.00	0.00	0.00	0.00	0.00
Basic EPS (Tax Loss Carry Forward)	0.00	0.00	0.00	0.00	0.00
Basic EPS (Other Gains/Losses)	0.00	0.00	0.00	0.00	0.00
Basic EPS - Total	1.11	0.57	0.43	0.55	0.32
Basic EPS - Normalized	1.11	0.57	0.43	0.55	0.32
*
Diluted EPS (Continuing)	0.98	0.52	0.41	0.53	0.32
Diluted EPS (Discontinued)	0.00	0.00	0.00	0.00	0.00
Diluted EPS from Total Operations	0.98	0.52	0.41	0.53	0.32
Diluted EPS (Extraordinary)	0.00	0.00	0.00	0.00	0.00
Diluted EPS (Cum. Effect of Acct. Change)	0.00	0.00	0.00	0.00	0.00
Diluted EPS (Tax Loss Carry Forward)	0.00	0.00	0.00	0.00	0.00
Diluted EPS (Other Gains/Losses)	0.00	0.00	0.00	0.00	0.00
Diluted EPS - Total	0.98	0.52	0.41	0.53	0.32
Diluted EPS - Normalized	0.98	0.52	0.41	0.53	0.32
Dividends Paid Per Share (DPS)	0.00	0.00	0.00	0.00	0.00
INCOME STATEMENT (YEAR-TO-DATE)
Revenue (YTD)	26.5	29.8	26.8	30.8	35.8
Net Income from Total Operations (YTD)	11.2	5.9	4.6	6.0	3.6
EPS from Total Operations (YTD)	0.98	0.52	0.41	0.53	0.32
Dividends Paid Per Share (YTD)	0.00	0.00	0.00	0.00	0.00
BALANCE SHEET
ASSETS
cash & equivalents	39.3	44.7	47.2	35.9	43.2
restricted cash	0.0	0.0	0.0	0.0	0.0
marketable securities	0.0	0.0	0.0	3.5	0.0
accounts receivable	2.4	2.1	3.5	5.8	5.4
loans receivable	0.0	0.0	0.0	0.0	0.0
other receivable	0.0	0.0	0.0	0.0	0.0
receivables	2.4	2.1	3.5	5.8	5.4
inventories, raw materials	1.8	0.0	2.9	2.7	2.6
inventories, work in progress	1.6	0.0	2.1	1.5	2.4
inventories, purchased components	0.0	0.0	0.0	0.0	0.0
inventories, finished goods	0.8	0.0	0.3	0.2	0.6
inventories, other	0.0	3.3	0.0	0.0	0.0
inventories, adjustments & allowances	0.0	0.0	0.0	0.0	0.0
inventories	4.2	3.3	5.4	4.4	5.5
prepaid expenses	1.3	1.0	0.2	1.2	0.5
current defered income taxes	1.8	1.3	1.3	1.7	1.2
other current assets	0.0	0.0	0.0	0.0	0.0
total current assets	49.1	52.4	57.6	52.4	55.8
land and improvements	0.0	0.0	0.0	0.0	0.0
building and improvements	3.4	0.0	3.5	11.6	11.6
machinery, furniture & equipment	7.0	11.9	7.3	8.4	9.3
construction in progress	0.0	0.0	2.4	8.1	21.6
other fixed assets	0.0	0.0	0.0	0.0	0.0
total fixed assets	10.3	11.9	13.3	28.1	42.4
gross fixed assets	10.3	11.9	13.3	28.1	42.4
accumulated depreciation	9.4	9.9	10.2	8.7	10.2
net fixed assets	1.0	2.1	3.0	19.4	32.2
intangibles	0.0	0.0	0.0	1.0	0.9
cost in excess	0.0	0.0	0.0	0.0	0.0
non-current deferred income taxes	9.4	8.0	7.3	6.3	6.3
other non-current assets	0.1	0.1	0.2	0.4	0.5
total non-current assets	10.5	10.2	10.5	27.1	40.0
total assets	59.5	62.6	68.1	79.5	95.8
inventory valuation method	2	2	2	2	2
EQUITY & LIABILITIES
accounts payable	0.8	1.3	1.0	4.9	2.4
notes payable	0.0	0.0	0.0	0.0	0.0
short-term debt	0.0	0.0	0.0	0.0	1.6
accrued expenses	2.0	1.7	1.6	2.8	0.0
accrued liabilities	0.0	0.0	0.0	0.0	2.3
deferred revenues	4.1	2.8	2.9	2.8	2.7
current deferred income taxes	0.0	0.0	0.0	0.0	0.0
other current liabilities	0.0	0.0	0.0	0.2	0.0
total current liabilities	6.9	5.8	5.5	10.6	9.0
long-term debt	0.0	0.0	0.0	0.0	14.4
capital lease obligations	0.0	0.0	0.0	0.0	0.0
deferred income taxes	0.0	0.0	0.0	0.0	0.0
other non-current liabilities	22.2	18.9	17.2	13.9	11.6
minority interest liability	0.0	0.0	0.0	0.0	0.0
preferred secur. of subsid. trust	0.0	0.0	0.0	0.0	0.0
preferred equity outside stock equity	0.0	0.0	0.0	0.0	0.0
total non-current liabilities	22.2	18.9	17.2	13.9	26.0
total liabilities	29.2	24.7	22.6	24.5	35.1
preferred stock equity	0.0	0.0	0.0	0.0	0.0
common stock equity	30.4	37.9	45.5	55.0	60.8
common par	0.1	0.1	0.1	0.1	0.1
additional paid-in capital	32.6	34.3	37.3	40.7	42.9
cumulative translation adjustments	0.0	0.0	0.0	0.0	0.0
retained earnings	-2.4	3.5	8.1	14.2	17.8
treasury stock	0.0	0.0	0.0	0.0	0.0
other equity adjustments	0.0	0.0	0.0	0.0	0.0
total capitalization	30.4	37.9	45.5	55.0	75.2
total equity	30.4	37.9	45.5	55.0	60.8
total liabilities & stock equity	59.5	62.6	68.1	79.5	95.8
*
cash flow	11.9	6.4	5.0	6.9	5.1
working capital	42.1	46.6	52.1	41.8	46.8
free cash flow	23.4	4.9	0.7	-10.3	-12.8
invested capital	30.4	37.9	45.5	55.0	75.2
*
shares out (common class only)	10.3	10.5	10.8	11.2	11.4
preferred shares	0.0	0.0	0.0	0.0	0.0
total ordinary shares	0.0	0.0	0.0	0.0	0.0
total common shares out	10.3	10.5	10.8	11.2	11.4
treasury shares	0.0	0.0	0.0	0.0	0.0
basic weighted shares	10.1	10.4	10.6	11.1	11.3
diluted weighted shares	11.4	11.4	11.2	11.5	11.5
number of employees	61	65	64	82	84
number of part-time employees	0	0	0	0	0
CASH-FLOW STATEMENT
OPERATING ACTIVITIES
net income/loss	11.2	5.9	4.6	6.0	3.6
depreciation	0.7	0.5	0.4	0.8	1.4
amortization	0.0	0.0	0.0	0.0	0.0
amortization of intangibles	0.0	0.0	0.0	0.0	0.0
deferred income taxes	-11.2	1.9	0.7	0.7	0.4
operating gains	0.7	1.2	0.0	0.0	0.0
extraordinary gains	0.0	0.0	0.0	0.0	0.0
(increase) decrease in receivables	-0.9	0.3	-1.4	-2.3	0.4
(increase) decrease in inventories	-0.6	0.8	-2.2	0.9	-1.3
(increase) decrease in prepaid expenses	-1.3	0.3	0.8	-1.0	0.9
(increase) decrease in other current assets	0.0	0.0	0.0	0.0	-0.1
decrease (increase) in payables	0.4	0.5	-0.3	1.1	-0.1
decrease (increase) in other current liabilities	24.8	-4.9	0.4	-2.3	-3.1
decrease (increase) in other working capital	0.0	0.0	-1.7	0.1	0.0
other non-cash items	0.0	0.0	0.8	0.4	1.3
net cash from continuing operations	23.8	6.5	2.0	4.5	3.4
net cash from discontinued operations	0.0	0.0	0.0	0.0	0.0
net cash from total operating activities	23.8	6.5	2.0	4.5	3.4
INVESTING ACTIVITIES
sale of property, plant & equipment	0.0	0.0	0.0	0.0	0.0
sale of long-term investments	0.0	0.0	0.0	0.0	0.0
sale of short-term investments	0.0	0.0	0.0	0.0	3.5
purchase of property, plant & equipment	-0.5	-1.6	-1.3	-14.8	-16.2
acquisitions	0.0	0.0	0.0	0.0	0.0
purchase of long-term investments	0.0	0.0	0.0	0.0	0.0
purchase of short-term investments	0.0	0.0	0.0	-3.5	0.0
other investing changes, net	0.8	0.0	0.0	0.0	-0.1
cash from discontinued investing activities	0.0	0.0	0.0	0.0	0.0
net cash from investing activities	0.3	-1.6	-1.3	-18.3	-12.8
FINANCING ACTIVITIES
issuance of debt	0.0	0.0	0.0	0.0	16.0
issuance of capital stock	0.6	0.6	1.2	1.9	0.5
repayment of long-term debt	0.0	0.0	0.0	0.0	0.0
repurchase of capital stock	0.0	0.0	0.0	0.0	0.0
payment of cash dividends	0.0	0.0	0.0	0.0	0.0
other financing charges, net	0.0	0.0	0.5	0.6	0.2
cash from discontinued financing activities	0.0	0.0	0.0	0.0	0.0
net cash from financing activities	0.6	0.6	1.7	2.5	16.7
NET CASH FLOW
effect exchange rate changes	0.0	0.0	0.0	0.0	0.0
net change in cash & equivalents	24.7	5.4	2.4	-11.3	7.3
cash at beginning of period	14.6	39.3	44.7	47.2	35.9
cash end of period	39.3	44.7	47.2	35.9	43.2
*
foreign sales	4.0	7.9	9.1	8.1	0.0
domestic sales	22.4	12.6	17.7	22.8	0.0
auditor name	PWC LLP	PWC LLP	PWC LLP	PWC LLP	PricewaterhouseCoopers LLP
auditor report	UQ	UQ	UQ	UQ	UQ
RATIOS CALCULATIONS
PROFIT MARGINS
Close PE Ratio	9.3	22.5	32.4	27.5	9.5
High PE Ratio	18.2	33.1	37.5	42.4	50.0
Low PE Ratio	6.6	15.5	22.9	23.0	9.3
gross profit margin	65.1	64.2	60.0	64.1	67.1
pre-tax profit margin	25.6	32.8	28.0	28.2	13.2
post-tax profit margin	42.3	19.8	17.2	19.6	10.1
net profit margin	42.3	19.8	17.2	19.6	10.1
interest coverage (cont. operations)	0.0	0.0	0.0	0.0	0.0
interest as % of invested capital	0.0	0.0	0.0	0.0	0.0
effective tax rate	0.0	39.8	38.8	30.5	23.2
income per employee	183443	90662	71941	73601	43202
NORMALIZED RATIOS
Normalized Close PE Ratio	9.3	22.5	32.4	27.5	9.5
Normalized High PE Ratio	18.2	33.1	37.5	42.4	50.0
Normalized Low PE Ratio	6.6	15.5	22.9	23.0	9.3
normalized net profit margin	42.3	19.8	17.2	19.6	10.1
Normalized ROE	36.9	15.6	10.1	11.0	6.0
Normalized ROA	18.8	9.4	6.8	7.6	3.8
Normalized ROCI	36.9	15.6	10.1	11.0	4.8
normalized income per employee	183443	90662	71941	73601	43202
SOLVENCY RATIOS
quick ratio	6.0	8.0	9.3	4.2	5.4
current ratio	7.1	9.0	10.5	4.9	6.2
payout ratio	0	0	0	0	0
total debt/equity ratio	0.00	0.00	0.00	0.00	0.26
long-term debt/total capital	0.00	0.00	0.00	0.00	0.19
EFFICIENCY RATIOS
leverage ratio	2.0	1.7	1.5	1.4	1.6
asset turnover	0.7	0.5	0.4	0.4	0.4
cash as % of revenue	148.6	150.0	175.7	116.5	120.7
receivables as % of revenue	8.9	6.9	13.1	18.8	15.1
SG&A as % of Revenue	22.8	18.1	24.9	25.9	30.6
R&D as % of Revenue	15.4	15.9	13.5	14.2	20.7
ACTIVITY RATIOS
revenue per $ cash	0.67	0.67	0.57	0.86	0.83
revenue per $ plant (net)	27.71	14.23	8.89	1.59	1.11
revenue per $ common equity	0.87	0.79	0.59	0.56	0.59
revenue per $ invested capital	0.87	0.79	0.59	0.56	0.48
LIQUIDITY RATIOS
receivables turnover	14.0	13.5	9.6	6.6	6.4
inventory turnover	2.4	2.9	2.5	2.3	2.4
receivables per day sales	32.02	24.93	47.07	67.68	54.51
sales per $ receivables	11.24	14.44	7.65	5.32	6.60
sales per $ inventory	6.26	9.12	4.97	7.02	6.48
revenue/assets	0.4	0.5	0.4	0.4	0.4
number of days cost of goods in inventory	153	126	145	159	152
current assets per share	4.79	4.99	5.35	4.67	4.91
total assets per share	5.80	5.96	6.32	7.08	8.42
intangibles as % of book-value	0.0	0.0	0.0	1.8	1.5
inventory as % of revenue	16.0	11.0	20.1	14.2	15.4
CAPITAL STRUCTURE RATIOS
long-term debt per share	0.00	0.00	0.00	0.00	1.27
current liabilities per share	0.68	0.55	0.51	0.95	0.79
cash per share	3.84	4.26	4.38	3.20	3.80
LT-Debt to Equity Ratio	0.00	0.00	0.00	0.00	0.24
LT-Debt as % of Invested Capital	0.0	0.0	0.0	0.0	19.2
LT-Debt as % of Total Debt	0.0	0.0	0.0	0.0	41.1
total debt as % total assets	49.0	39.5	33.2	30.9	36.6
working captial as % of equity	138.8	122.9	114.6	76.1	77.0
revenue per share	2.58	2.84	2.49	2.75	3.14
book value per share	2.96	3.61	4.22	4.90	5.34
tangible book value per share	2.96	3.61	4.22	4.81	5.26
price/revenue ratio	3.55	4.12	5.33	5.29	0.97
price/equity ratio	3.09	3.24	3.14	2.97	0.57
price/tangible book ratio	3.09	3.24	3.14	3.02	0.58
working capital as % of price	44.9	38.0	36.5	25.6	135.2
PROFITABILITY
working capital per share	4.11	4.44	4.84	3.72	4.11
cash flow per share	1.16	0.60	0.46	0.61	0.45
free cash flow per share	2.28	0.46	0.06	-0.91	-1.13
Return on Stock Equity (ROE)	36.9	15.6	10.1	11.0	6.0
Return on Capital Invested (ROCI)	36.9	15.6	10.1	11.0	4.8
Return on Assets (ROA)	18.8	9.4	6.8	7.6	3.8
price/cash flow ratio	7.9	19.5	28.8	23.9	6.8
price/free cash flow ratio	4.0	25.4	221.2	-16.0	-2.7
sales per employee	433869	459000	419385	375973	425952
AGAINST THE INDUSTRY RATIOS
% of sales-to-industry	0.1	0.1	0.1	0.1	0.1
% of earnings-to-industry	-8.1	0.7	-0.2	0.3	1.6
% of EPS-to-Industry	-612.5	-58.4	-83.7	588.9	-172.0
% of price-to-industry	47.5	51.9	68.9	88.1	17.3
% of PE-to-Industry	0.0	0.0	0.0	15.0	0.0
% of price/book-to-industry	84.9	74.0	83.1	93.1	16.5
% of price/sales-to-industry	52.0	56.4	96.6	110.9	21.8
% of price/cashflow-to-industry	9.4	27.7	1.5	65.0	11.5
% of pric/free cashlow-to-industry	-1.0	6.8	-298.6	-16.5	1.4
% of debt/equity-to-industry	0.0	0.0	0.0	0.0	57.1
% of current ratio-to-industry	229.0	257.1	362.1	175.0	200.0
% of gross profit margin-to-industry	77.4	76.1	70.0	75.9	83.8
% of pre-tax profit margin-to-industry	393.8	318.4	2000.0	290.7	206.3
% of post-tax profit margin-to-industry	-8460.0	825.0	-256.7	576.5	1683.3
% of net profit margin-to-industry	-8460.0	761.5	-245.7	376.9	2020.0
% of ROE-to-Industry	0.0	1040.0	0.0	314.3	1500.0
% of leverage-to-industry	125.0	106.3	88.2	77.8	88.9

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

34 site:2us nasdaq anik100209 15:18